IL1A and type 2 diabetes mellitus: Il1α, together with Il1β, belongs to the interleukin-1 family, which has been much more studied in the context of metabolic diseases, and its inhibition is one of the pharmacological strategies being tested as a treatment for type 2 diabetes [51].